<DOC>
	<DOCNO>NCT02028260</DOCNO>
	<brief_summary>This randomize , double-blind , placebo control study 30 patient . Patients qualify , per inclusion criterion ( RASS great -3 , less +1 , CAM positive , present gastric access ) either give 200mg modafinil identical , indistinguishable placebo . The placebo study drug distribute hospital pharmacy . Once enrolled , patient reassess every morning determine appropriateness drug administration . If RASS le -3 ( i.e . comatose ) great 0 modafinil give . He/she assess morning thereafter . Due stimulant-like action modafinil , drug administer morning . Patients assessed delirium least twice day ; train personnel use Confusion Assessment Method ( CAM ) assessment . Qualification delirium free day positive CAM screen 24 hour follow drug administration . Additional data day mechanical ventilation progression tracheotomy also collect hypothesize patient take modafinil short time extubation therefore avoid need tracheotomy . Post-discharge unit , within 48 hour , patient ask participate survey ( The Richards-Campbell Sleep Questionnaire ( RCSQ ) assess perception daytime nighttime sleepiness intensive care unit well overall perception rest . Their functional capacity also evaluate time compare pre-morbid baseline . The hypothesis test Modafinil restores sleep cycle synchrony ICU therefore increase delirium free day improve ICU outcome .</brief_summary>
	<brief_title>Modafinil Versus Placebo Hypoactive Delirium Critically Ill</brief_title>
	<detailed_description>Eligibility Criteria Inclusion Criteria To eligible study entry , subject must satisfy main criterion Inclusion criterion : 3.1 Inclusion Criteria - Adult patient ≥ 18 yrs age , &lt; 76 yr age - Admitted MICU ( 3B 3C ) SICU ( 8C , 8D , 11C ) - Surrogate present provide inform consent patient able - RASS score &gt; -3 , &lt; +1 - CAM positive - Enteral access 3.2 Exclusion Criteria : - Recent MI ( within past 2 week ) - High risk dysrhythmias ( i.e . bundle branch block , QT prolongation , class IV HF , implanted device ) - Unable tolerate enteral medication - History stimulant induce mania/psychosis - Pre-existing neurologic disease - Patients transfer outside hospital - Pregnancy - Alcohol withdrawal - History end stage liver disease ( Childs-Pugh class B worse ) - Prognosis consider hopeless ( CMO )</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Inclusion Criteria Adult patient ≥ 18 yrs age , &lt; 76 yr age Admitted MICU ( 3B 3C ) SICU ( 8C , 8D , 11C ) Surrogate present provide inform consent patient able RASS score &gt; 3 , &lt; +1 CAM positive Enteral access Recent MI ( within past 2 week ) High risk dysrhythmias ( i.e . bundle branch block , QT prolongation , class IV HF , implanted device ) Unable tolerate enteric medication History stimulant induce mania/psychosis Preexisting neurologic disease Patients transfer outside hospital Pregnancy Alcohol withdrawal History end stage liver disease ( ChildsPugh class B worse ) Prognosis consider hopeless ( CMO )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>